Lung Therapeutics Inc. 13D and 13G filings for TFF Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 3:32 pm Sale | 2022-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | Lung Therapeutics Inc. | 30,920 2.100% | -58,480 (-65.41%) | Filing |
| 2022-02-14 3:07 pm Sale | 2021-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | Lung Therapeutics Inc. | 89,400 8.810% | -28,600 (-24.24%) | Filing |
| 2021-02-03 3:10 pm Sale | 2020-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | Lung Therapeutics Inc. | 118,000 13.300% | -42,000 (-26.25%) | Filing |